Actuate Therapeutics, Inc. Common stock (ACTU)
Healthcare
Biotechnology
1.10 $
-5.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Actuate Therapeutics, Inc. Common stock (ACTU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -5.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.1 | -5.6 | -5.5 | -5.2 | -2.7 | -9.1 | -4.8 | -4.6 | -4.2 | -6.7 | -3.7 | -5.0 | -20 | |
| 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.6 | 1.2 | 1.1 | 1.6 | 1.8 | 1.5 | 1.4 | 6.3 | |
| 0.5 | 0.6 | 1.9 | 2.4 | 2.7 | -4.4 | 0.5 | 0.6 | 0.2 | -3.1 | -0.7 | -0.9 | -4.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| 1.7 | 0.0 | 0.0 | 4.4 | 1.0 | 22 | -0.1 | -0.1 | 6.8 | 17 | 0.0 | 0.0 | 24 | |
| -3.4 | -5.6 | -5.5 | -0.9 | -1.7 | 13 | -4.9 | -4.8 | 2.6 | 10 | -3.8 | -5.0 | 4.2 | |
| -5.1 | -5.6 | -5.5 | -5.2 | -2.7 | -9.1 | -4.8 | -4.6 | -4.2 | -6.7 | -3.7 | -5.0 | -20 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.